Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Exagen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $148.8K in total
- Insiders trading
- 1
- Net value
- −$148.8K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Exagen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Black Jeffrey G. | Chief Financial Officer | 324,910 | Sep 2, 2026 | 3 |
| Robertson Bruce C | Director | – | Aug 24, 2026 | 1 |
| Kim Paul | Director | – | Aug 19, 2026 | 1 |
| Kahn Scott D | Director | – | Jun 22, 2026 | 1 |
| McKhann Chas | Director | – | Jun 22, 2026 | 1 |
| Stokes Frank | Director | – | Jun 22, 2026 | 1 |
| Aballi John | President and CEO | 839,834 | Mar 16, 2026 | 4 |
| Nova Tina Susan | Director | – | Jun 12, 2025 | 0 |
| Hooker Ana | Director | – | Jun 12, 2025 | 0 |
| NMSIC Co-Investment Fund, L.P. | 10% Owner | 1,758,958Indirect | Mar 27, 2025 | 0 |
| Sun Mountain Capital Partners LLC | 10% Owner | 1,758,958Indirect | Mar 27, 2025 | 0 |
| Adawi Kamal | CFO and Corporate Secretary | 243,749 | Mar 6, 2024 | 0 |
| Tullis James L L | 10% Owner | 1,515,839Indirect | Jun 20, 2023 | 0 |
| Tullis Growth Fund II, L.P. | 10% Owner | 1,515,839Indirect | Jun 20, 2023 | 0 |
| Pallares Ebetuel | Director | – | Jun 13, 2023 | 0 |
| Birk Brian | Director | – | Jun 13, 2023 | 0 |
| Johnson Wendy S. | Director | 1,000 | Jun 13, 2023 | 0 |
| Hazeltine Mark | Chief Business Officer | 190,205 | Mar 3, 2023 | 0 |
| Rocca Fortunato R. | President and CEO | 120,678 | Mar 2, 2022 | 0 |
| Zack Debra | Chief Medical Officer | 84,259 | Mar 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)5:39 PM ET | Sep 1 | 1 day | Black Jeffrey G.Chief Financial Officer | SSale | −20.6K | $7.22 | −$148.8K | −6.0%323.3K after | |
| Mar 4, 2026 (view filing) | Mar 3 | 1 day | Aballi JohnPresident and CEO | SSale | −15.7K | $3.62 | −$56.8K | −2.2%687.3K after | |
| Feb 25, 2026 (view filing) | Feb 24 | 1 day | Aballi JohnPresident and CEO | SSale | −11.4K | $3.61 | −$41.3K | −1.6%703.0K after | |
| Feb 25, 2026 (view filing) | Feb 24 | 1 day | Black Jeffrey G.Chief Financial Officer | SSale | −1.58K | $3.61 | −$5.72K | −0.6%267.4K after | |
| Oct 20, 2025 (view filing) | Oct 16 | 4 days | Aballi JohnPresident and CEO | SSale | −31.8K | $11.82 | −$375.7K | −4.3%714.4K after | |
| Sep 4, 2025 (view filing) | Sep 2 | 2 days | Black Jeffrey G.Chief Financial Officer | SSale | −20.5K | $9.79 | −$200.4K | −7.1%269.0K after | |
| Mar 27, 2025 (view filing)4:15 PM ET | Mar 25 | 2 days | NMSIC Co-Investment Fund, L.P. and 1 other10% Owner | SSale | −350.0K | $3.30 | −$1.16M | −16.6%1.76M after | |
| Nov 27, 2024 (view filing)4:18 PM ET | Nov 20 | 7 daysLate | NMSIC Co-Investment Fund, L.P. and 1 other10% Owner | SSale | −200.0K | $3.30 | −$660.0K | −8.7%2.11M after | |
| Nov 19, 2024 (view filing) | Nov 15 | 4 days | Black Jeffrey G.Chief Financial Officer | PPurchase | +22.3K | $2.98 | +$66.4K | +8.8%274.5K after | |
| Nov 18, 2024 (view filing) | Nov 14 | 4 days | Aballi JohnPresident and CEO | PPurchase | +24.3K | $2.81 | +$68.3K | +3.7%689.8K after | Amended |
| May 16, 2024 (view filing) | May 16 | Same day | Aballi JohnPresident and CEO | PPurchase | +40.4K | $1.92 | +$77.6K | New position40.4K after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Adawi KamalCFO and Corporate Secretary | SSale | −12.8K | $1.91 | −$24.4K | −5.0%243.7K after | 2 lots |
| Feb 8, 2024 (view filing) | Feb 6 | 2 days | Adawi KamalCFO and Corporate Secretary | SSale | −6.74K | $1.95 | −$13.1K | −3.6%181.5K after | |
| Oct 18, 2023 (view filing) | Oct 17 | 1 day | Aballi JohnPresident and CEO | SSale | −33.8K | $1.75 | −$59.2K | −7.5%416.0K after | |
| Jun 20, 2023 (view filing)5:04 PM ET | Jun 15 | 5 days | Tullis James L L and 1 other10% Owner | PPurchase | +167 | $3.11 | +$519.45 | 0.0%1.52M after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Adawi KamalCFO and Corporate Secretary | SSale | −3.67K | $2.30 | −$8.43K | −1.9%188.3K after | |
| Mar 3, 2023 (view filing) | Mar 2 | 1 day | Hazeltine MarkChief Business Officer | SSale | −3.67K | $0.00 | $0 | −1.9%190.2K after | |
| Feb 10, 2023 (view filing) | Feb 8 | 2 days | Hazeltine MarkChief Business Officer | SSale | −5.82K | $2.69 | −$15.7K | −5.8%93.9K after | |
| Feb 10, 2023 (view filing) | Feb 8 | 2 days | Adawi KamalCFO and Corporate Secretary | SSale | −5.82K | $2.69 | −$15.7K | −6.0%91.9K after | |
| Dec 9, 2022 (view filing) | Dec 8 | 1 day | Aballi JohnPresident and CEO | PPurchase | +90.0K | $2.68 | +$241.2K | +25.7%440.0K after | |
| Sep 7, 2021 (view filing) | Sep 3 | 4 days | Johnson Wendy S.Director | PPurchase | +1.00K | $14.02 | +$14.0K | New position1.00K after | |
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Tullis James L LDirector | SSale | −6.80K | $10.72 | −$72.9K | −0.4%1.52M after | |
| Aug 4, 2021 (view filing) | Aug 2-4 | 2 days | Tullis James L LDirector | SSale | −8.20K | $11.71 | −$96.0K | −0.5%1.52M after | 3 lots |